The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19

There is a need for treatments to reduce coronavirus disease 2019 (COVID-19) mortality. Alpha-2 adrenergic receptor (α2 AR) agonists can dampen immune cell and inflammatory responses as well as improve oxygenation through physiologic respiratory parameters. Therefore, α2 AR agonists may be effective...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	John L. Hamilton, Mona Vashi, Ekta B. Kishen, Louis F. Fogg, Markus A. Wimmer, Robert A. Balk
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2022-01-01
Цуврал:	Frontiers in Medicine
Нөхцлүүд:	coronavirus disease 2019 (COVID-19) dexmedetomidine mortality severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) alpha-2 adrenergic receptor agonist
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fmed.2021.797647/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!